Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on June 25, 2009

Cardiovascular Research, doi:10.1093/cvr/cvp213
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
84/2/237    most recent
cvp213v2
cvp213v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bányász, T.
Right arrow Articles by Nánási, P. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bányász, T.
Right arrow Articles by Nánási, P. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.

Reverse rate dependency is an intrinsic property of canine cardiac preparations

Tamás Bányász1, Balázs Horváth1, László Virág2, László Bárándi1, Norbert Szentandrássy1, Gábor Harmati1, János Magyar1, Stefano Marangoni3, Antonio Zaza3, András Varró2,4 and Péter P. Nánási1

1 Department of Physiology, University of Debrecen, Debrecen, Hungary
2 Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary
3 Dipartimento di Biotecnologie e Bioscienze, Universita di Milano-Bicocca, Milano, Italy
4 Division of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary

Correspondence: Péter P Nánási, Department of Physiology, University of Debrecen, H-4012 Debrecen, Nagyerdei krt 98, Hungary. Phone/Fax: +36-52-416634 / +36-52-432289, E-mail: nanasi{at}phys.dote.hu

Aims: Class III antiarrhythmic agents exhibit reverse rate-dependent lengthening of the action potential duration (APD). In spite of the several theories developed so far to explain this reverse rate-dependency (RRD), its mechanism has not yet been clarified. The aim of the present work was to further elucidate the mechanisms responsible for reverse rate-dependent drug effects.

Methods: Action potentials were recorded from multicellular canine ventricular preparations and isolated cardiomyocytes, at cycle lengths (CL) varying from 0.3 to 5 s, using conventional sharp microelectrodes. APD was either modified by applying inward and outward current pulses, or by superfusion of agents known to lengthen and shorten APD. Net membrane current (Im) was calculated from action potential waveforms. The hypothesis that RRD may be implicit in the relationship between Im and APD was tested by numerical modeling.

Results: Both drug-induced lengthening (by veratrine, BAY-K 8644, dofetilide, and BaCl2) and shortening (by lidocaine and nicorandil) of action potentials displayed RRD, i.e. changes in APD were greater at longer than at shorter CL. A similar dependency of effect on CL was found when repolarization was modified by injection of inward or outward current pulses. Im measured at various points during repolarization was inversely proportional to APD and to CL. Model simulations showed that RRD is expected as a consequence of the non-linearity of the relationship between Im and APD.

Conclusions: RRD of APD modulation is shared, although with differences in magnitude, by interventions of very different nature. RRD can be interpreted as a consequence of the relationship between Im and APD and, as such, is expected in all species having positive APD-CL relationship. This implies that development of agents prolonging APD with direct rate-dependency, or even completely devoid of RRD, may be difficult to achieve.

KEYWORDS Action potential duration; Reverse rate dependence; Ventricular repolarization; Membrane current; Dog myocytes


Time for primary review: 22 Days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.